-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UR0OZmWZnEgF7BcUUUhY3vGyA4Y0sE+np1eRqeOe82xkjZ9CQk0Q5g07CxJIxma9 xl32QNYAClxf9yZrThSlzQ== 0001209191-09-011948.txt : 20090226 0001209191-09-011948.hdr.sgml : 20090226 20090226180940 ACCESSION NUMBER: 0001209191-09-011948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090224 FILED AS OF DATE: 20090226 DATE AS OF CHANGE: 20090226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Topper James N CENTRAL INDEX KEY: 0001341382 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24274 FILM NUMBER: 09639074 BUSINESS ADDRESS: BUSINESS PHONE: (650) 325-5156 MAIL ADDRESS: STREET 1: 550 HAMILTON AVENUE, SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO CENTRAL INDEX KEY: 0000920465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330361285 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584526600 MAIL ADDRESS: STREET 1: 6455 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2009-02-24 0 0000920465 LA JOLLA PHARMACEUTICAL CO LJPC 0001341382 Topper James N 70 WILLOW ROAD SUITE 200 MENLO PARK CA 94025 1 0 0 0 Common Stock 2009-02-24 4 S 0 1662000 0.0727 D 4210711 I Frazier Healthcare V, LP Common Stock 2009-02-25 4 S 0 1454000 0.0633 D 2756711 I Frazier Healthcare V, LP Common Stock 2009-02-26 4 S 0 2756711 0.0562 D 0 I Frazier Healthcare V, LP This row reports all sales on 02-24-09 at the weighted average sales price indicated in column 4 for all sales on that date. The range of prices on this day was $0.10-$0.065. Upon request the reporting person will provide to the SEC, the issuer or any security holder of the issuer full information regarding the number of shares sold at each separate price. These securities are owned directly by Frazier Healthcare V, LP. The general partner of Frazier Healthcare V, LP is FHM V, LP. FHM V, LLC is the general partner of FHM V, LP. Mr. Topper is one of seven managing members of FHM V, LLC. Mr. Topper disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein and this report shall not be deemed an admission of ownership of these shares by Mr. Topper for purposes of Section 16 or otherwisee. This row reports all sales on 02-25-09 at the weighted average sales price indicated in column 4 for all sales on that date. The range of prices on this day was $0.055- $0.0702. Upon request, the reporting person will provide to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares sold at each separate price. This row reports all sales on 02-26-09 at the weighted average sales price indicated in column 4 for all sales on that date. The range of prices on this day was $0.05-$0.062. Upon request, the reporting person will provide to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares sold at each separate price. /s/ James Topper James N. Topper 2009-02-26 -----END PRIVACY-ENHANCED MESSAGE-----